-
CAR T-cell Therapies: Takeaways and Best Practices for Strategy Planning
Chimeric antigen receptor (CAR) T-cell therapies are the newest drug class in the continued development of personalized oncology treatments. The introduction of CAR T-cell therapy to aggressive...
-
Technological Innovation in the UK National Health Service
Technological Innovation in the UK National Health Service This Executive Briefing on Technological innovation in the UK National Health Service (NHS) provides an overview of some of the challenges...
-
Rise of ICER
Rise of ICER Straining from ever-rising drug spending, U.S. payers are increasingly turning to and leveraging the cost-effectiveness analysis generated by the Institute for Clinical and Economic...
-
Advanced Targeting: Activating Networks of Influence
It’s increasingly complicated to find and prioritize the right HCP mix, and pull the right levers to influence the treatment journey. Learn how advanced targeting can help.
-
Innovation in Oncology: Key Drug Classes, Takeaways and Best Practices for Strategic Planning
Cancer patients have a more favorable outlook today than ever before thanks to major improvements in care developed over recent years, and emerging treatment innovation in the pipeline will continue...
-
Ramping up to 2019: Five Trends to Watch in Medtech
The landscape for healthcare continues to undergo several significant changes. Top DRG Medtech analysts and consultants weigh in on five of them: the emergence of mega health systems, evolutions in...
-
Market Snapshot: Cardiac Rhythm Management
DRG has delved into the competitive cardiac rhythm management market, analyzing factors such as market share and facility penetration by competitor. Check out our snapshot on the cardiac rhythm...
-
Libtayo's FDA Approval: What to Expect from this Novel PD-1 Inhibitor
Libtayo's FDA Approval: What to Expect from this Novel PD-1 Inhibitor Dr. Andrew Merron, Executive Director, DRG Oncology A true milestone event in oncology occurred this September 2018 when the FDA...
-
Cardiovascular and Orthopedic Device Markets in China: The Rise of Domestic Competitors
This live session took place on September 20, 2018 Rapid growth in the Chinese cardiovascular and orthopedic market and large foreseeable opportunities have attracted significant investment from both...
-
Market Snapshot: Neurostimulation
DRG, in partnership with Bloomberg Intelligence, has delved into the competitive neurostimulation market, analyzing factors such as market share and hospital penetration by brand. Check out our...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
